U.S. market Closed. Opens in 7 hours 54 minutes

ELV | Elevance Health Inc. Stock Overview

(Stock Exchange: NYSE)
Day's Range 391.22 - 400.01
52 Week Range 391.22 - 567.26
Beta 0.81
Implied Volatility 27.51%
IV Rank 66.12%
Day's Volume 2,028,064
Average Volume 1,495,231
Shares Outstanding 231,923,000
Market Cap 92,184,754,040
Sector Healthcare
Industry Medical - Healthcare Plans
IPO Date 2001-10-30
Valuation
Profitability
Growth
Health
P/E Ratio 14.46
Forward P/E Ratio 13.96
EPS 27.48
1YR Price Target 576.00
Dividend Yield 1.65%
Dividend Per Share 6.57
Dividend ExDate 2023-03-09
Dividend PayDate 2023-03-24
Employees 104,900
Country USA
Website ELV
Elevance Health (formerly known as Anthem) remains one of the leading health insurers in the U.S., providing medical benefits to roughly 47 million medical members as of September 2022. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid, too.
ELV's peers: ALHC, CI, CNC, CVS, HUM, MOH, OSCR, UNH
*Chart delayed
Analyzing fundamentals for ELV we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is poor, Growth is very good and Health is passable. For more detailed analysis please see ELV Fundamentals page.

Watching at ELV technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ELV Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙